Stay updated on Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page.

Latest updates to the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page
- Check4 days agoChange Detected- Revision notice updated to v3.3.3 in the footer; the HHS Vulnerability Disclosure link and the previous revision note v3.3.2 were removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page; no changes to the study details, inclusion/exclusion criteria, or primary outcomes were observed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe funding-status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedThe study status was updated to Terminated due to insufficient enrollment, with enrollment listed as 10. The update changes core trial data shown on the study record.SummaryDifference0.5%

- Check83 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check90 days agoChange DetectedCore content updated with a terminology rearrangement from 'Malignant mesothelioma' to 'Mesothelioma, malignant' and a version bump to v3.1.0, indicating an overall refresh rather than changes to pricing or availability.SummaryDifference0.3%

Stay in the know with updates to Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page.